newsfilter
← Latest News
PR Newswire·

PDL BioPharma Completes Divestiture of the Noden Pharmaceutical Business to Stanley Capital

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the closing of the sale of its wholly owned subsidiaries Noden Pharma DAC and...